Thiamidol Cream for Dark Spots: The 2026 Trial’s Mixed Results

Before buying a cream for a facial patch, ask what kind of pigmentation you are trying to treat and how you will judge a change. A patch that looks lighter in a standardized photograph may still bother you in the mirror. Both observations belong in a treatment review.

What the 0.2% cream trial found

The 2026 Bangkok trial¹ randomized 200 adults, including 168 women, to 0.2% thiamidol cream or vehicle cream twice daily for 12 weeks. Both groups used UVA-protective SPF-30 sunscreen; 196 participants completed treatment.¹

Average modified Melasma Area and Severity Index scores fell by 36.1% with thiamidol and 16.1% with vehicle, a significant difference. This was a physician assessment of standardized photographs.¹

However, patient ratings and digital color analysis showed no significant advantage. Physician assessments of freckles, solar lentigines and post-inflammatory pigmentation also found no significant between-group benefit. These smaller subsets included only 12 people with solar lentigines.¹

Beiersdorf provided the cream and study funding. One coauthor was a company employee; thiamidol is patented by Beiersdorf.¹

The results support discussing the tested formula and its measured effect. They cannot establish that every thiamidol product will produce the same result or that every type of dark spot will respond.

Confirm which condition the patch represents

Dermatologists can often diagnose melasma by examining the face and neck. A Wood’s lamp or dermatoscope may help assess pigment depth. Sometimes a biopsy is needed because another condition resembles melasma.²

Bring the patch’s timeline, whether it followed acne or irritation, and the products you have already applied. Ask: “Is this melasma, a mark left by inflammation, or something else? Which evidence fits that diagnosis?”

The diagnosis and treatment guidance from the American Academy of Dermatology² describes a plan tailored to skin tone, pigment depth and triggers. It includes sun protection, often alongside prescribed medication. Results commonly take three to 12 months, sometimes longer with longstanding melasma.²

That treatment timeline is broader than one cream trial. Agree on a review date and the outcome that matters to you, such as a change in the patch’s extent, contrast or appearance without makeup. Ask how the clinician will assess it.

Keep sun protection in the plan

For melasma, self-care guidance recommends a broad-spectrum, water-resistant sunscreen with SPF 30 or higher, applied before going outside and reapplied at least every two hours. Shade, sun-protective clothing and a wide-brimmed hat also help limit exposure.³

Visible light can worsen melasma, particularly in darker skin tones. The guidance recommends a tinted sunscreen containing iron oxide as well as SPF protection. It also advises gentle, fragrance-free skin care: a product that burns or stings is irritating the skin and may darken existing spots.³

Take your sunscreen and other active products to the consultation. Ask where a new cream would fit, which products should continue and what irritation would mean you should stop and contact the clinician. Starting several products together makes it harder to identify which one caused a reaction.

Compare photographs without losing the patient’s view

Choose a consistent window or lamp, camera position and distance for follow-up photographs. Record the product, start date, use and any itching or stinging. Avoid judging one photograph taken in bright daylight against another taken under a warm bathroom bulb.

Bring both the photographs and your own assessment. “The patch looks smaller in the photo, but I still cover it every morning” is useful information about whether the change has met your goal.

Skin, Head to Toe, Chapter 8’s “Dark Mark or Scar?”, distinguishes flat pigment from changes in skin texture and recommends same-light photographs in the Skin Log. That distinction helps define the concern before you evaluate a cream’s claim.